A new research finding established that the ‘Collateral Blood Flow’ is an important determinant of outcome in patients with acute ischemic stroke who are undergoing endovascular therapy.
David Liebeskind and his team of research scientists at the University of California at Los Angeles Stroke Center, United States carried out an intensive research study that concluded with such findings. These findings with all relevant details and analyses have also been published in the “Journal of Neurology, Neurosurgery, and Psychiatry” recently.
“Considering that ‘recanalization’ is often achieved in only a fraction of cases undergoing endovascular therapy, further research on collateral circulation and related therapeutic approaches is warranted,” says David Liebeskind the lead researcher from the “University of California at Los Angeles Stroke Center, USA”.
